Istituto Scientifico Universitario San Raffaele

Milan 20132

0 studies enrolling now · 4 studies all time

What they study most

ALK+ Advanced NSCLC, Advanced Cholangiocarcinoma, Advanced Malignancies, Carcinoma, Lung Cancer, Metastatic Cholangiocarcinoma, Non-small Cell Lung Cancer, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Studies at this site

• A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia — Running, not enrolling
• A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer — Completed
• Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy) — Completed
• ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants — Completed